Intrinsiqq
Ucb SA logo

Ucb SA Quality Score

UCB.XBRU

Compare
Quality80

Growth remains strong (avg 100/100), but valuation is pulling the composite down (avg 50/100).

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
40/100
34.8x

Above 30x, priced for sustained outperformance

Cash Flow Multiple
60/100
28.9x

25–30x, paying up for cash generation

Revenue Growth
100/100
12.0%

Above 10% CAGR, strong compounder

Cash Flow Growth
100/100
35.0%

Above 10% CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution
60/100
0.3%

Mild dilution under 2%

Margin Trend
100/100
+13.2pp

Expanded 3+pp, strong improvement

Capital Structure
100/100
-€202M

Net cash position, no leverage concern

2022
€1.14B
€2.90B
2023
€1.06B
€3.04B
2024
€1.76B
€3.03B
2025
€2.45B
€2.25B
CashDebt
Return on Capital
60/100
13.1%

10–15%, respectable returns

Customize WeightsPremiumUpgrade

Ucb SA (UCB.XBRU) quality: score, margins and returns

Ucb SA (UCB.XBRU) scores 80/100 on Intrinsiqq's quality score (a high-quality business), a weighted blend of 8 metrics each scored 0 to 100, on 25.9% operating margins and 13.1% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Ucb SA (UCB.XBRU) a high-quality business?+

Ucb SA scores 80 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a high-quality business on these measures. Recent figures include a 25.9% operating margin and a 13.1% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Ucb SA's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from UCB.XBRU's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Ucb SA scores well and where it falls behind.

What is Ucb SA's return on invested capital (ROIC)?+

Ucb SA earns about 13.1% on its invested capital, which is solid. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to UCB.XBRU's margins and growth on this scorecard to judge durability.

How profitable is Ucb SA?+

Ucb SA runs an operating margin of about 25.9% and a net margin of about 20.1%. Revenue has grown at roughly 7.6% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Peers

Biotechnology · Pick stocks to compare with UCB.XBRU

CompareIntrinsic value
FAGR.XBRUFagron NV
€24.65+1.02%78
GRFSGrifols S.A. ADR
$8.15-0.61%63
APOTEA.XSTOApotea AB
€9.00-0.94%71
SYNSAM.XSTOSynsam AB
€5.31-2.03%79
ICLRICON plc
$186.71-1.92%23
LONN.XSWXLonza Group AG
CHF 652.40-2.34%17
SNNSmith & Nephew plc Sponsored ADR
$29.83+0.00%69
BAVA.XCSEBavarian Nordic A/S
€33.58+2.88%84

Held by ETFs

UCB.XBRU is in 149 US ETFs. The largest of them, with UCB.XBRU's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing UCB.XBRU

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.